Jeffrey Aronson

Q: What Schools Are Affiliated With Jeffrey Aronson

Jeffrey Aronson is affiliated with the following schools: University of Cape Town, University of Oxford

Jeffrey Aronson's AcademicInfluence.com Rankings

Jeffrey Aronson

Medical

#549

World Rank

#743

Historical Rank

Pharmacology

#40

World Rank

#55

Historical Rank

medical Degrees

Download Badge

Medical

Jeffrey Aronson's Degrees

Masters Medicine University of Cape Town

Why Is Jeffrey Aronson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jeffrey Kenneth Aronson is a British clinical pharmacologist. Education Aronson studied at the University of Glasgow from 1964 to 1970, qualifying with the degree of MBChB, and after primary medical training in Glasgow hospitals joined the Medical Research Council's Unit and University Department of Clinical Pharmacology in Oxford, qualifying DPhil Oxon in 1977.

(See a Problem?)

Jeffrey Aronson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Adverse drug reactions: definitions, diagnosis, and management (2000) (2476)
A new taxonomy for describing and defining adherence to medications. (2012) (1349)
STROCSS 2019 Guideline: Strengthening the Reporting of Cohort Studies in Surgery. (2019) (1024)
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology (2009) (792)
CARE guidelines for case reports: explanation and elaboration document. (2017) (736)
Safety (2009) (674)
What is a clinical trial? (2004) (608)
Evaluation and stages of surgical innovations (2009) (522)
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature (2016) (367)
New Labour, New Language? (2000) (341)
Medication errors: definitions and classification. (2009) (340)
Chloroquine and hydroxychloroquine in covid-19 (2020) (340)
Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions (2006) (278)
Medication errors: what they are, how they happen, and how to avoid them. (2009) (267)
Joining the DoTS: new approach to classifying adverse drug reactions (2003) (248)
Clarification of Terminology in Drug Safety (2005) (243)
Osteoarthritis of the young adult hip: etiology and treatment. (1986) (232)
Oxford Textbook of clinical pharmacology and drug therapy (1985) (214)
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. (1996) (198)
The Need for Randomization in Animal Trials: An Overview of Systematic Reviews (2014) (195)
The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute? (2009) (194)
Grapes (1998) (173)
Biomarkers and surrogate endpoints. (2005) (167)
Overdiagnosis: what it is and what it isn’t (2018) (161)
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. (1982) (153)
Anecdotes that provide definitive evidence (2006) (152)
The road to health care (2004) (147)
Clarification of Terminology in Medication Errors (2006) (142)
Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial (2011) (141)
Compliance, concordance, adherence. (2007) (141)
A prescription for better prescribing (2006) (140)
Biomarkers—A General Review (2017) (133)
Clarification of terminology in medication errors: definitions and classification. (2006) (133)
Defining 'nutraceuticals': neither nutritious nor pharmaceutical. (2017) (127)
All-Cause and Cardiovascular Mortality in Middle-Aged People With Type 2 Diabetes Compared With People Without Diabetes in a Large U.K. Primary Care Database (2013) (122)
Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions (2009) (119)
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. (1982) (115)
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials (2001) (113)
Drugs and the renin-angiotensin system in covid-19 (2020) (109)
Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial (2003) (107)
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review (2016) (100)
Case reports of suspected adverse drug reactions—systematic literature survey of follow-up (2006) (98)
A prescription for better prescribing (2006) (86)
Anecdotes as evidence (2003) (86)
Evidence-based mechanistic reasoning (2010) (85)
Redefining rapid reviews: a flexible framework for restricted systematic reviews (2018) (82)
Adverse events in people taking macrolide antibiotics versus placebo for any indication. (2015) (81)
Remdesivir in covid-19 (2020) (81)
Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests (2018) (81)
Clinical Pharmacokinetics of Digoxin 1980 (1980) (79)
Communicating information about drug safety (2006) (79)
Medication errors, worse than a crime (2000) (78)
Overtesting and undertesting in primary care: a systematic review and meta-analysis (2018) (76)
Inhibition of Na+/K+-ATPase may be one mechanism contributing to potassium efflux and cell shrinkage in CD95-induced apoptosis (2000) (75)
Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis (2016) (75)
Rare diseases and orphan drugs. (2006) (74)
Catalogue of bias: attrition bias (2018) (71)
Autopathography: the patient's tale (2000) (69)
Medication errors: problems and recommendations from a consensus meeting. (2009) (64)
A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone. (2004) (62)
Identification of Ehrlichia in human tissue. (1991) (62)
Preventability of Drug-Related Harms — Part I (2010) (61)
Paradoxical and Bidirectional Drug Effects (2012) (61)
Problems with using mechanisms to solve the problem of extrapolation (2013) (60)
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. (1980) (59)
Meta- (2002) (59)
ABC of Monitoring Drug Therapy (1993) (59)
Reduced Salt Intake for Heart Failure: A Systematic Review (2018) (59)
Potassium channels in nervous tissue. (1992) (58)
Medicinal plants in folk tradition: an ethnobotany of Britain and Ireland (2005) (58)
Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process (2017) (58)
Tranylcypromine (‘Parnate’) overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma (1979) (56)
Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses (2021) (55)
Poor medication adherence in clinical trials: consequences and solutions (2017) (55)
In defence of polypharmacy. (2004) (54)
Defining rewardable innovation in drug therapy (2012) (54)
Compliance, adherence, and concordance (2005) (54)
Old drugs--new uses. (2007) (52)
Unlicensed and off‐label uses of medicines: definitions and clarification of terminology (2017) (51)
Identification of system y+L as the high-affinity transporter for l-arginine in human platelets: up-regulation of l-arginine influx in uraemia (1999) (50)
Rational prescribing, appropriate prescribing. (2004) (50)
Gold Standards in Pharmacovigilance (2006) (50)
Adverse drug reactions: keeping up to date (2002) (50)
Altered in vitro adaptive responses of lymphocyte Na+,K(+)-ATPase in patients with manic depressive psychosis. (1991) (49)
Altered distribution of digoxin in renal failure--a cause of digoxin toxicity? (1976) (49)
What is the evidence for social distancing during global pandemics (2020) (48)
Abnormal function of potassium channels in platelets of patients with Alzheimer's disease (1998) (47)
Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response. (1977) (46)
Transvaginal mesh failure: lessons for regulation of implantable devices (2017) (46)
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. (2020) (45)
Comparison of essential medicines lists in 137 countries (2019) (45)
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis (2015) (45)
Medication errors resulting from the confusion of drug names. (2004) (45)
NICE and new: appraising innovation (2010) (43)
“Where name and image meet”—the argument for “adrenaline” (2000) (43)
Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis. (2015) (43)
Evidence for altered Na+/H+ antiport activity in cultured skeletal muscle cells and vascular smooth muscle cells from the spontaneously hypertensive rat. (1991) (42)
WHEN I USE A WORD.. (1996) (42)
Polypharmacy, appropriate and inappropriate. (2006) (42)
A manifesto for clinical pharmacology from principles to practice. (2010) (42)
Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity. (1978) (40)
Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation. (1979) (40)
Balanced prescribing. (2006) (40)
Preventability of Drug-Related Harms — Part II (2010) (38)
Distinguishing Hazards and Harms, Adverse Drug Effects and Adverse Drug Reactions (2013) (37)
EIDOS: a mechanistic classification of adverse drug effects. (2010) (37)
ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements. (1993) (37)
Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment. (1989) (36)
Identification of system y (1999) (34)
ABC of monitoring drug therapy. Patient compliance. (1992) (34)
Classifying drug interactions. (2004) (34)
Prolonged half-life of verapamil in a case of overdose: implications for therapy. (1995) (34)
ABC of monitoring drug therapy. Measuring plasma drug concentrations. (1992) (34)
Evidence-based medical monitoring : (2008) (33)
Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore. (2007) (33)
Stephens' detection and evaluation of adverse drug reactions : principles and practice (2011) (33)
Risk perception in drug therapy. (2006) (33)
Please, please me (1999) (33)
Balanced prescribing – principles and challenges (2012) (32)
Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy (2011) (30)
Structural requirements for voltage‐dependent block of muscle sodium channels by phenol derivatives (2001) (30)
The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy. (1979) (30)
Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes. (1985) (30)
Errors in prescribing, preparing, and giving medicines: definition, classification, and prevention (1999) (29)
ABC of monitoring drug therapy. Lithium. (1992) (28)
Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions. (2005) (28)
Something New Every Day: Defining Innovation and Innovativeness in Drug Therapy (2008) (28)
Me‐too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists (2020) (27)
Evidence for increased in vivo Na(+)-H+ antiporter activity and an altered skeletal muscle contractile response in the spontaneously hypertensive rat. (1990) (27)
Standardization of symbols in clinical pharmacology (2004) (27)
An improved model for the binding of lidocaine and structurally related local anaesthetics to fast‐inactivated voltage‐operated sodium channels, showing evidence of cooperativity (2004) (27)
Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease. (1992) (26)
Induction of oxidative stress and TNF-alpha secretion by dichloroacetonitrile, a water disinfectant by-product, as possible mediators of apoptosis or necrosis in a murine macrophage cell line (RAW). (2000) (25)
Evidence-based Medical Monitoring: From Principles to Practice (2008) (25)
Research priorities in biomarkers and surrogate end-points. (2012) (25)
Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis (2021) (25)
Terrorist (2002) (24)
Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution. (1977) (24)
Drug interactions-information, education, and the British National Formulary. (2004) (24)
ABC of monitoring drug therapy. Digoxin. (1992) (24)
The use of colour vision measurement in the diagnosis of digoxin toxicity. (1980) (24)
The problem of look‐alike, sound‐alike name errors: Drivers and solutions (2020) (24)
Communicating information about drug interactions (2007) (24)
Clinical pharmacology--providing tools and expertise for translational medicine. (2008) (24)
Medical Devices: Definition, Classification, and Regulatory Implications (2019) (24)
Adverse events in patients taking macrolide antibiotics versus placebo for any indication (Protocol) (2015) (24)
Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis (2013) (24)
ABC of monitoring drug therapy. Aminoglycoside antibiotics. (1992) (23)
Stephens’ Detection of New Adverse Drug Reactions (2004) (23)
What's in a brand name? (1994) (23)
Susceptibility to adverse drug reactions. (2019) (23)
Adverse drug reactions--no farewell to harms. (2007) (23)
Measurement of specific [3H]-ouabain binding to different types of human leucocytes. (1984) (23)
An Account of the Foxglove and Its Medical Uses 1785-1985 (1986) (23)
Key concepts for making informed choices (2019) (22)
Monitoring digoxin therapy: III. How useful are the nomograms? (1978) (22)
Medication errors: EMERGing solutions. (2009) (22)
Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP) (2016) (21)
Methods for expressing the characteristics of transmembrane ion transport systems. (1990) (21)
The use of mechanistic evidence in drug approval (2018) (21)
Meyler Side Effects of Analgesics and Anti inflammatory Drugs (2010) (21)
Defining ‘Surveillance’ in Drug Safety (2012) (21)
From prescription-only to over-the-counter medicines ('PoM to P'): time for an intermediate category. (2009) (21)
The upregulation of Na+,K(+)-ATPase pump numbers in lymphocytes from the first-degree unaffected relatives of patients with manic depressive psychosis in response to in vitro lithium and sodium ethacrynate. (1995) (21)
Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability (2012) (20)
A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride. (1984) (20)
Pharmacokinetic investigation of the interaction of azapropazone with phenytoin. (1983) (20)
The Effect of Lithium on Cation Transport Measured in vivo in Patients Suffering from Bipolar Affective Illness (1989) (19)
Naltrexone-bupropion (Mysimba®) in management of obesity: a systematic review and meta-analysis of unpublished clinical study reports. (2020) (19)
ABC of monitoring drug therapy. Phenytoin. (1992) (19)
Clinical Pharmacokinetics of Cardiac Glycosides in Patients with Renal Dysfunction (1983) (19)
Checklist for standardized reporting of drug–drug interaction management guidelines (2014) (19)
National differences in publishing papers on adverse drug reactions. (2005) (19)
Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16 (2018) (19)
Clinical pharmacology and therapeutics in the UK--a great instauration. (2010) (18)
An Introduction to Monitoring Therapeutic Interventions in Clinical Practice (2008) (18)
Digoxin therapy: textbooks, theory and practice. (1976) (18)
Can understanding mechanisms solve the problem of extrapolating from study to target populations (the problem of ‘external validity’)? (2013) (18)
Monitoring drug therapy. (2012) (17)
Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits. (1983) (17)
Clinical pharmacology. Adverse drug interactions. (1981) (17)
One Man's Medicine (2003) (17)
The law of mass action and the pharmacological concentration–effect curve: resolving the paradox of apparently non‐dose‐related adverse drug reactions (2016) (17)
Block of voltage‐operated sodium channels by 2,6‐dimethylphenol, a structural analogue of lidocaine's aromatic tail (2002) (17)
An agenda for UK clinical pharmacology: Monitoring drug therapy: Commentary (2012) (17)
Pharmacological evidence of calcium-activated and voltage-gated potassium channels in human platelets. (1997) (17)
Pycnodysostosis and the making of an artist. (2015) (16)
Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacology (2016) (16)
Antiseptic drugs and disinfectants (2014) (16)
Sodium-lithium countertransport in erythrocytes of pregnant women. (1982) (16)
Transdermal hyoscine (scopolamine) and postoperative vomiting (1986) (16)
IS A SLOW PULSE-RATE A RELIABLE SIGN OF DIGITALIS TOXICITY? (1978) (16)
Inhibiting the proton pump: mechanisms, benefits, harms, and questions (2016) (16)
Chickenpox (2000) (16)
Confusion Over Similar Drug Names (1995) (16)
Enhancement of specific [3H]ouabain binding and ouabain sensitive 86rubidium influx in intact human lymphocytes by a dialysable factor in human and fetal calf serum. (1987) (16)
Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (16)
Cation transport abnormalities in vivo in untreated essential hypertension. (1986) (16)
Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis (2020) (16)
What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists. (2012) (16)
Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems. (2017) (16)
Paradoxical reactions: Under-recognized adverse effects of drugs? (2006) (16)
Concentration-effect and dose-response relations in clinical pharmacology. (2007) (15)
Medication errors detected in non-traditional databases: types of errors in methotrexate dosing as listed in four different Danish registers (2015) (15)
A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy (2013) (15)
Drugs for rare disorders (2017) (15)
Medicalization (2002) (15)
ABC of monitoring drug therapy. Theophylline. (1992) (15)
Commentary: Open access publishing: too much oxygen? (2005) (15)
Short‐ and medium‐term effects of light to moderate alcohol intake on glycaemic control in diabetes mellitus: a systematic review and meta‐analysis of randomized trials (2017) (15)
Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names (2015) (15)
Disposition in normal volunteers of sodium azodisalicylate, a potential therapeutic agent in inflammatory bowel disease (1981) (15)
INTERACTION OF DIGOXIN WITH QUININE (1981) (15)
Medical eponyms: taxonomies, natural history, and the evidence (2014) (14)
Diagnostic test guidelines based on high-quality evidence had greater rates of adherence: a meta-epidemiological study. (2018) (14)
Antibiotics policies in the developing world (2004) (14)
Changing beta-blockers in heart failure: when is a class not a class? (2008) (14)
Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists (2020) (14)
Measurement of cation transport in vivo in healthy volunteers after the oral administration of lithium carbonate. (1989) (14)
That's show business (1999) (13)
Time to abandon the term ‘patient concordance’ (2007) (13)
Evidence for increased in vivo sodium-potassium pump activity and potassium efflux in skeletal muscle of spontaneously hypertensive rats. (1990) (13)
John Marshall's first description of surgical electrocautery (2011) (13)
Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review (2018) (13)
Medication errors resulting from the confusion of drug names (2004) (13)
The effects of serum, lithium, ethacrynic acid, and a low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes after incubation for 3 days. (1986) (13)
NSAIDs and gut toxicity (1994) (13)
Structural features of phenol derivatives determining potency for activation of chloride currents via α1 homomeric and α1β heteromeric glycine receptors (2005) (13)
Journal Clubs: 2. Why and how to run them and how to publish them (2017) (13)
A Strategy for Regulatory Action When New Adverse Effects of a Licensed Product Emerge (2009) (13)
Dermatological drugs, topical agents, and cosmetics (2008) (12)
Over-the-counter medicines. (2004) (12)
Voltage‐dependent blockade of normal and mutant muscle sodium channels by benzylalcohol (2000) (12)
Serious drug interactions. (1993) (12)
The toxicological significance of post-mortem drug concentrations in bile (2018) (12)
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity (2022) (12)
Cardiac glycosides and drugs used in dysrhythmias (1984) (12)
A non-invasive method of measuring concentrations of rubidium in rat skeletal muscle in vivo by 87Rb nuclear magnetic resonance spectroscopy: implications for the measurement of cation transport activity in vivo. (1990) (12)
Biomarkers and Surrogate Endpoints in Monitoring Therapeutic Interventions (2008) (12)
Erythrocytic cation transport receptor numbers and activity in pregnancies complicated by essential hypertension and pre-eclampsia. (1984) (12)
Interaction of azapropazone with phenytoin. (1982) (12)
Medication reconciliation (2017) (12)
Dietary salt and hypertension: treatment and prevention. (1985) (12)
Effects of haemodialysis and continuous ambulatory peritoneal dialysis on abnormalities of ion transport in vivo in patients with chronic renal failure. (1993) (12)
Oxford Handbook of Practical Drug Therapy (2011) (12)
Intravenous strontium gluconate as a kinetic marker for calcium in healthy volunteers. (1991) (12)
A word about evidence: ‘rapid reviews’ or ‘restricted reviews’? (2018) (12)
Plagiarism - please don't copy. (2007) (11)
Increases in Na/K pump numbers in isolated human lymphocytes exposed to lithium in vitro. Reversal by myo-inositol and by inhibitors of protein kinase C and the Na/H antiport. (1991) (11)
Wellcome witnesses to twentieth-century medicine (1998) (11)
Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD (2019) (11)
Clinical Pharmacology: Past, Present, and Future (2006) (11)
Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories (2021) (10)
Coroners’ concerns to prevent harms: a series of coroners’ case reports to serve patient safety and educate the public, clinicians and policy-makers (2020) (10)
Poor prescribing is continual (2006) (10)
Effects of antihypertensives, lipid-modifying drugs, glycaemic control drugs and sodium bicarbonate on the progression of stages 3 and 4 chronic kidney disease in adults: a systematic review and meta-analysis (2019) (10)
The $800 Million Pill: The Truth Behind the Cost of New Drugs (2004) (10)
On the waterfront – the breadth and depth of clinical pharmacology (2004) (10)
Structural features of phenol derivatives determining potency for activation of chloride currents via alpha(1) homomeric and alpha(1)beta heteromeric glycine receptors. (2005) (10)
Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. (1980) (10)
A Dictionary of Pharmacology and Allied Topics (2nd edition): edited by Desmond Laurence, with contributions from John Carpenter (1999) (10)
How to attract, retain and nurture young academic clinicians (2011) (10)
The Measurement of Transmembrane Cation Transport in vivo in Acute Manic Illness (1989) (9)
Drug therapy in kidney disease. (2007) (9)
Crisis in the supply of medicines (2019) (9)
The pharmacokinetics of L-tryptophan following its intravenous and oral administration. (1985) (9)
How similar are biosimilars? (2016) (9)
Meyler's side effects of herbal medicines. (2009) (9)
Timentin therapy for bone, joint, and deep soft tissue infections in children. (1985) (9)
Metabolism of an oral tryptophan load III: effect of a pyridoxine supplement. (1980) (9)
The effects of a low extracellular concentration of potassium on the activity and numbers of Na+/K+ pumps in an EB-virus transformed human lymphocyte cell line. (1990) (9)
Prescribing biosimilars (2018) (9)
Drug development: more science, more education. (2005) (9)
Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning (2020) (8)
The NSAID roller coaster: more about rofecoxib. (2006) (8)
ABC of monitoring drug therapy. Cyclosporin. (1992) (8)
Single screening or double screening for study selection in systematic reviews? (2019) (8)
Immunohistologic Demonstration of Ehrlichia canis (1990) (8)
Ten essential papers for the practice of evidence-based medicine (2017) (8)
One hundred years of atrial fibrillation. (2005) (8)
Thyroid hormones, iodine and iodides, and antithyroid drugs (2014) (8)
Rapidly managing pneumonia in older people during a pandemic (2020) (8)
Patent medicines and secret remedies (2009) (8)
Positive inotropic drugs and drugs used in dysrhythmias (1990) (8)
76 – Plant Poisons and Traditional Medicines (2014) (8)
Methods for meta-analysis of pharmacodynamic dose–response data with application to multi-arm studies of alogliptin (2018) (8)
Increase in Na+/K+ pump numbers in vivo in healthy volunteers taking oral lithium carbonate and further upregulation in response to lithium in vitro. (1992) (8)
From basic to clinical neuropharmacology: targetophilia or pharmacodynamics? (2012) (7)
The Diagnosis of Art: Arthrogryposis and Ribera's The Clubfoot (2006) (7)
Deaths from cardiovascular disease involving anticoagulants: a systematic synthesis of coroners’ case reports (2021) (7)
The effect of β2-adrenoceptor stimulation and blockade of L-type calcium channels on in vivo Na+/H+ antiporter activity in rat skeletal muscle (1991) (7)
A sensitive high-temperature electrothermal atomic absorption analysis for Rb+ in erythrocytes and plasma of normal and hypertensive persons. (1985) (7)
A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole. (1989) (7)
Deaths attributed to the use of medications purchased online (2021) (7)
Balancing benefits and harms in health care (2004) (7)
The use of mechanistic reasoning in assessing coronavirus interventions (2020) (7)
Editors’ view Compliance, concordance, adherence (2007) (7)
Oral hormone pregnancy tests and the risks of congenital malformations: a systematic review and meta-analysis. (2018) (7)
When I use a word ... declarative titles. (2010) (7)
The role of the Na+, K+-ATPase in the regulation of vascular smooth-muscle contractility, and its relationship to essential hypertension. (1984) (7)
Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines (2012) (7)
Withdrawn medicines included in the essential medicines lists of 136 countries (2019) (7)
Side Effects of Drugs Annual 2. A Worldwide Yearly Survey of New Data and Trends (1978) (7)
Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension (1993) (6)
The diagnosis of art: Durer's squint – and Shakespeare's? (2009) (6)
The diagnosis of art: melancholy and the portrait of Dr. Gachet. (2006) (6)
Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study (2021) (6)
Failed phlebotomy? Think William Harvey (2014) (6)
Publishing Histories of Adverse Reactions to Medicaments Anecdotally (2008) (6)
Prescribing statins. (2005) (6)
Medicines regulation and clinical pharmacology (2004) (6)
Modelling circadian variation in the pharmacokinetics of non-steroidal anti-inflammatory drugs (2004) (6)
Routes of drug administration: uses and adverse effects: Part 1: Intramuscular and subcutaneous injection (2008) (6)
Phantastica (2007) (6)
Prevention of acute adverse reactions to snake antivenom after snakebite: multi-centre, randomized, controlled clinical trial (2009) (6)
Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature (2019) (6)
On Being 30 (2004) (6)
When I use a word . . . . Listening to the patient (2022) (6)
Drug withdrawals because of adverse effects (2008) (6)
Case Reports as Evidence in Pharmacovigilance (2014) (6)
Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950–1980) (2018) (6)
Na+/H+ and HCO3-/Cl- exchange in the control of intracellular pH in vivo in the spontaneously hypertensive rat. (1991) (6)
The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers. (1991) (6)
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic (2021) (6)
The ethics of COVID-19 treatment studies: too many are open, too few are double-masked (2020) (6)
The Surgeon of Crowthorne: A Tale of Murder, Madness and the Love of Words (1998) (6)
50 - Medication errors (2008) (6)
“Collaborative care” is preferable to “patient centred care” (2016) (6)
A Systematic Review and Empirical Analysis of the Relation Between Dose and Duration of Drug Action (2010) (6)
Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and Limitations (2022) (6)
Multiple-dose activated charcoal in yellow oleander poisoning (2008) (6)
John Bostock's first description of hayfever (2011) (5)
An in vivo study of cation transport in essential hypertension. (1984) (5)
The UK's NHS and pharma: need for more clinical pharmacologists (2009) (5)
ABC of monitoring drug therapy. Why monitor drug therapy? (1992) (5)
When I use a word: Bottled lightning (2005) (5)
Monitoring therapy. (2005) (5)
Examining the ‘psychopharmacology revolution’ (1950–1980) through the advertising of psychoactive drugs in the British Medical Journal (2018) (5)
Journal Clubs: 1. Origins (2017) (5)
Reducing prescription errors (2010) (5)
What is a ‘complex systematic review’? Criteria, definition, and examples (2018) (5)
When I use a word ... words misheard: medical mondegreens. (2009) (5)
When I use a word . . . . Too much healthcare—overdetection (2022) (5)
Nurse prescribers & reporters. (2003) (5)
Comprar Meyler's Side Effects Of Cardiovascular Drugs | J.K Aronson | 9780444532688 | Academic Press (2009) (5)
Citation classics in the British Journal of Clinical Pharmacology, 1974-2003. (2004) (5)
INCREASED SPECIFIC [H-3] OUABAIN BINDING TO LYMPHOCYTES AFTER INCUBATION WITH ACETYLSTROPHANTHIDIN FOR 3 DAYS (1985) (5)
Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification (2017) (5)
Evidence for an R(+)-[(dihydroindenyl)oxy]alkanoic acid-sensitive K+/Cl- co-transporter in human platelets and its interaction with the Na+/K+/2Cl- co-transporter. (1997) (5)
Appendix 2: Guidelines and a Checklist for Reporting Suspected Adverse Drug Reactions Anecdotally in Journals (2012) (5)
Clinical chronopharmacology. Concepts, kinetics, application. (1991) (5)
Francis Galton and the invention of terms for quantiles. (2001) (5)
When I use a word . . . . The Precautionary Principle: a brief history (2021) (4)
Cytostatic and cytotoxic drugs (2014) (4)
THE EFFECT OF LITHIUM ON CATION-TRANSPORT INVIVO AND INVITRO IN HEALTHY-VOLUNTEERS (1987) (4)
Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives (2020) (4)
Lorcaserin in obesity: minimal benefits and ill-defined harms (2019) (4)
Chapter 9 – Anti-inflammatory and antipyretic analgesics and drugs used in gout (2009) (4)
The Bengt Erik Wiholm Lecture 2017: The Language of Pharmacovigilance (2017) (4)
Routes of drug administration: uses and adverse effects: Part 2: sublingual, buccal, rectal, and some other routes (2009) (4)
When I use a word...materia medica, clinical pharmacology, and therapeutics. (2010) (4)
Preventable suicides: a systematic analysis of coroners’ prevent future death reports in England and Wales (2020) (4)
X marks the spot (1999) (4)
Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports (2015) (4)
Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm. (2005) (4)
Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy (1981) (4)
Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy. (1981) (4)
When I use a word . . .: Medicalization (2002) (4)
MONITORING LITHIUM TREATMENT - REPLY (1993) (4)
The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers. (1990) (4)
Meyler's side effects of drugs used in cancer and immunology (2010) (4)
Proactive Pharmacovigilance and Risk Management (2012) (4)
The effect of beta 2-adrenoceptor stimulation and blockade of L-type calcium channels on in vivo Na+/H+ antiporter activity in rat skeletal muscle. (1991) (4)
Time for category of pharmacist consultation and supply (2009) (4)
John and James Parkinson's first description of acute appendicitis and its associated complications of perforation and death (2011) (4)
Selected National Pharmacovigilance Websites (2012) (4)
Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta‐Analysis (2018) (4)
Finding a VOICE for UK clinical pharmacology. (2012) (4)
The diagnosis of art: Caravaggio's jaundiced Bacchus (2007) (4)
Integrating pharmacology and clinical pharmacology. (2011) (4)
Phenol derivatives accelerate inactivation kinetics in one inactivation-deficient mutant human skeletal muscle Na(+) channel. (2001) (4)
Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)—variants in the spellings of drug names in PubMed: a database review (2016) (4)
Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis (2017) (4)
A brief history of clinical evidence updates and bibliographic databases (2018) (4)
The effects of digoxin and dopamine on the oxygen consumption, lactate production and haemodynamic performance of an isolated, perfused, working guinea-pig heart. (1982) (4)
Drugs and renal insufficiency (2003) (4)
When I use a word: Sometimes, never (2006) (4)
When I use a word . . . . The Precautionary Principle: a definition (2021) (3)
Therapeutics and good prescribing (2010) (3)
When I use a word . . . . No jab, no job? A benefit:harm balance analysis (2021) (3)
Jacob Lockhart Clarke's and John Hughlings Jackson's first description of syringomyelia (2012) (3)
Drugs that act on the immune system: cytokines and monoclonal antibodies (2014) (3)
An agenda for research on adverse drug reactions. (2007) (3)
When I use a word... Fulsomely banning 'compendious'. (2009) (3)
Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (3)
Adverse effects of nitrous oxide (2014) (3)
Management of pain during injection of propofol (2014) (3)
The Oxford Catalogue of Opioids: A systematic synthesis of opioid drug names and their pharmacology (2021) (3)
When I use a word: Dropsy (2003) (3)
The discovery of the foxglove as a therapeutic agent (1987) (3)
The World Health Organization (WHO) essential medicines list (2005) (3)
Iatrogenic chest pain: a case of 5-fluorouracil cardiotoxicity. (1996) (3)
When I use a word...: Rabid responses (2005) (3)
Bottled lightning (2005) (3)
Littluns and biguns (2004) (3)
The effects on salbutamol on in vivo cation transport (1988) (3)
When I use a word ... Misunderspellings. (2011) (3)
Sodium valproate: who knew what and when? Cumulative meta-analysis gives extra insights (2018) (3)
Chronopharmacology: reflections on time and a new text (1990) (3)
Editors' view : Monitoring therapy (2005) (3)
Louis Lewin—Meyler's predecessor (2004) (3)
Today's science, tomorrow's medicines (2006) (3)
The Effects of Digoxin on Red Cell Digitalis Receptor Function in Man (1980) (3)
Towards a single VOICE for European clinical pharmacology: proposals for future developments (2013) (3)
Malignant disease and immunosuppression (2011) (3)
WHEN I USE A WORD (1996) (3)
Oral hormone pregnancy tests and the risks of congenital malformations: a systematic review and meta-analysis (2018) (3)
Medicines and the media (2006) (3)
When I use a word . . . . Too much healthcare—overconfidence (2022) (3)
When I use a word . . . . Too much healthcare—uncertainty, underconfidence, and masterly inactivity (2022) (3)
It does all depend on the dose. Understanding beneficial and adverse drug effects since 1864 : Clinical and experimental attitudes to the Law of Mass Action and concentration–effect curves (2018) (3)
When I use a word: Meta- (2002) (3)
When I use a word . . .: Chickenpox (2000) (3)
Reversal of the effects of a low extracellular potassium concentration on the number and activity of Na+/K+ pumps in an Epstein-Barr virus-transformed human lymphocyte cell line. (1992) (3)
STIMULATION OF TRITIATED-OUABAIN BINDING TO INTACT HUMAN-LYMPHOCYTES BY NORMAL HUMAN AND FETAL CALF SERUM (1983) (3)
In vivo cation transport during short-term and long-term digoxin therapy. (1986) (3)
When I use a word . . . . Memory, semantic and episodic (2022) (3)
When I use a word ... Is it inflammation? It is! (2009) (3)
ESSENTIAL ESSAYS (1987) (3)
When I use a word . . . . Too much healthcare—overdiagnosis (2022) (3)
Montelukast and Suicide: Causality Assessment Using Spontaneous Reports and Bradford Hill Guidelines (2011) (3)
The diagnosis of art: Scleroderma in Paul Klee – and Rembrandt's scholar? (2010) (3)
Glycosides of plants and men (1986) (3)
Frederick Treve's first surgical operation for appendicitis (2011) (3)
When I use a word . . . . Language games (2023) (3)
When I use a word . . . . Too much healthcare—Biomarkers (2022) (2)
When I use a word . . . . Too much healthcare—overdefinition (2022) (2)
When I use a word . . . . Medical anniversaries in 2023 (2023) (2)
Why reports of clinical trials should include updated meta-analyses (2019) (2)
Cheque your spelling (2000) (2)
Surrogate end points: studying their benefits, taxonomy, and semantics (2012) (2)
When I use a word . . . . Taking therapeutic care (2021) (2)
When I use a word . . . . Too much healthcare—self-assessment (2022) (2)
The Diagnosis of Art: Exophthalmos—Gustave Doré's Ogre (2006) (2)
Monitoring for the Adverse Effects of Drugs (2008) (2)
When I use a word . . . . Medical words newly logged in the OED in September 2021 (2022) (2)
The Diagnosis of Art: Diastrophic Dysplasia and Hephaistos (2006) (2)
The diagnosis of art: Valentin le désossé and Ehlers-Danlos syndrome. (2007) (2)
Live long and prosper: a mass strategy for treating the factors associated with ischaemic heart disease and stroke. (2004) (2)
9 Roundtable on philosophy of evidence: ‘dimensions of evidence and criteria for standards improvement’ (2018) (2)
Correction: Variation in diagnostic test requests and outcomes: A preliminary metric for OpenPathology.net (Scientific Reports DOI: 10.1038/s41598-018-23263-z) (2018) (2)
The Diagnosis of Art: Melancholy and the Portrait of Dr Gachet (2006) (2)
The diagnosis of art: Albrecht Dürer and the Christ Child's drooped shoulder (2008) (2)
A systematic review and meta-analysis of the effects of diuretics and beta-blockers on glycaemic control in diabetes mellitus (2014) (2)
The diagnosis of art: WH Auden's face (2011) (2)
Re: re- (2001) (2)
When I use a word . . . . Counterfactual medical history: Milton’s blindness (2022) (2)
Combining and converting groups when extracting data for meta-analysis (2021) (2)
Immunological products and vaccines (2011) (2)
Words that count (2007) (2)
Dealing with categorical risk data when extracting data for meta-analysis (2021) (2)
Oranges and grapefruit (1999) (2)
Rates of exchange (1991) (2)
When I use a word . . .: Overate? (2000) (2)
When I use a word . . . . Too much healthcare—too much of everything (2022) (2)
Rabid responses (2005) (2)
Assessment of Digoxin Action by a Pharmacodynamic Biochemical Method (1978) (2)
Effects of high external concentrations of K+ on 86Rb+ efflux in human platelets: evidence for Na+/K+/2Cl- co-transport. (1996) (2)
Poor medication adherence in clinical trials: consequences and solutions (2017) (2)
Editors' Report 2005 (2006) (2)
When I use a word . . . . Too much healthcare—observational studies (2022) (2)
Monitoring for harms of therapy. (2006) (2)
Colourful metals (2007) (2)
Changes in plasma tryptophan following a naturally enhanced source: a pharmacokinetic study. (2003) (2)
Evidence for Increased In Vivo Na+/H+ -Antiporter Activity in Skeletal Muscle of Spontaneously Hypertensive Rats (1990) (2)
Medicines legislation and regulation in the United Kingdom 1500‐2020 (2022) (2)
Introducing the EBM Verdict: research evidence relevant to clinical practice (2019) (2)
The diagnosis of art: exophthalmos--Gustave Doré's ogre. (2006) (2)
Chapter 2 Cardiovascular system (2005) (2)
Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature (2020) (2)
No effect (2007) (2)
Formularies and pharmacopoeias (2011) (2)
Extracting data from diagnostic test accuracy studies for meta-analysis (2021) (2)
Cardiac arrhythmias: theory and practice. (1985) (2)
When I use a word . . .“Well tolerated” is intolerable (2014) (2)
Non-existent authors (2017) (2)
Beneficial drug interactions. (1994) (2)
Harms and the Xmas factor (2020) (2)
Tocilizumab and mortality in hospitalised patients with covid-19. A systematic review comparing randomised trials with observational studies (2021) (2)
Give a drug a good name (2007) (2)
When I use a word . . . . Medical anniversaries in 2022 (2022) (2)
Hard data, soft data (2012) (2)
When I use a word . . . . Too much medicine (2022) (2)
Five types of skepticism (2015) (2)
When I use a word . . . Medical definitions: Pharmacovigilance (2023) (2)
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic analysis of coroners case reports from the COVID-19 pandemic (2021) (2)
NSAIDs and gut toxicity. (1994) (2)
When I use a word . . . . Diagnosis (2022) (2)
ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM (1982) (2)
Lack of effect of phenytoin on functions related to Na+,K+-ATPase activity of the intact erythrocytes of epileptic patients. (1981) (2)
How a VOICE for clinical pharmacology turns into a RECIPE for its development (2016) (1)
When I use a word . . . . New medical words 1422–1972 (2022) (1)
Too much healthcare (2022) (1)
Measurement ofspecific (:3H)-ouabain binding todifferent types ofhumanleucocytes (1984) (1)
Internationality: Editors' and publisher's view (2005) (1)
Side Effects of Drugs Essay: Classifying adverse drug reactions in the 21st century (2005) (1)
WHEN I USE A WORD.. (1996) (1)
Studies of the clinical pharmacology of cardiac glycosides (1977) (1)
EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY (1984) (1)
WHEN I USE A WORD.. (1996) (1)
Routes of drug administration: 1. Rectal (1991) (1)
Thepharmacokinetics ofL-tryptophan following its intravenous andoral administration (1985) (1)
Giampaolo Velo 1943-2017. (2018) (1)
When I use a word: Anecdotage (2003) (1)
When I use a word ... Ordinary words with extraordinary meanings. (2008) (1)
When I use a word…: Sausages (1997) (1)
When I use a word...sex, gender and segeny. (2011) (1)
Calcium-activated and ATP-dependent potassium channels in human platelets (1996) (1)
The Doctor in Literature: Volume 2, Private Life (2007) (1)
44 - Drugs that affect lipid metabolism (2010) (1)
THE EFFECT OF A LOW EXTERNAL POTASSIUM CONCENTRATION ON THE NA/K-ATPASE OF HUMAN-LYMPHOBLASTS (1987) (1)
When I use a word . . . Medical definitions: Pharmacovigilant surveillance (2023) (1)
Too high a pedestal (2008) (1)
Found in translation (2011) (1)
A systematic literature review of LASA error interventions (2020) (1)
The diagnosis of art: Sir George Savile, 8th Baronet – the ears have it? (2008) (1)
Developing Monitoring Tools: Integrating the Pathophysiology of Disease and the Mechanisms of Action of Therapeutic Interventions (2008) (1)
Chapter 6 Endocrine system; obstetrics and gynaecology (2005) (1)
General principles of drug therapy in psychiatry (2012) (1)
When I use a word . . . . Sydenham Societies (2022) (1)
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature (2022) (1)
Nutrition and blood (2011) (1)
Effects of serum, lithium, ethacrynic acid, and low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes—a reply (1987) (1)
Lessons from working across fields to develop a framework for informed choices (2022) (1)
Features of this month's. (2003) (1)
When I use a word . . . . Too much healthcare—technology (2022) (1)
Adverse events in patients taking cephalosporins versus placebo for any indication (2016) (1)
Dropsy (2003) (1)
When I use a word . . . : Grapes (1998) (1)
The diagnosis of art: Van Gogh and male pattern baldness (2009) (1)
When I use a word . . . . Counterfactual medical history: Milton’s treatment (2022) (1)
When I use a word…: Wool gathering (1997) (1)
The diagnosis of art: arthrogryposis and Ribera's The Clubfoot. (2006) (1)
Pharmacogenetics and adverse drug reactions (2010) (1)
What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries (2017) (1)
When I use a word: Consultation (2006) (1)
Indications for the Measurement of Plasma Digoxin Concentrations (2012) (1)
Drugs that act on the immune system (2011) (1)
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22 (2023) (1)
Towards improved drug-drug interaction management guidelines (2013) (1)
Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries, states, and territories (2020) (1)
Overate? (2000) (1)
Editors' Report 2004 (2005) (1)
Post-Approval Withdrawal of Medicines Because of Adverse Drug Reactions: A Systematic Review (2015) (1)
Placebo's invisible brother: a restricted scoping review of biomedical literature on the nocebo effect. (2022) (1)
Side effects of drugs essay: Observational studies in assessing benefits and harms: double standards? (2014) (1)
Comprar Meyler Side Effects of Analgesics and Anti inflammatory Drugs | Jeffrey K. Aronson | 9780444532732 | Academic Press (2010) (1)
Correction: Ten essential papers for the practice of evidence-based medicine (2018) (1)
When I use a word . . . . Data—certainly plural, rarely singular (2023) (1)
The Blood Doctor (2002) (1)
Modern English abusage (2000) (1)
When I use a word . . . . Information (2023) (1)
Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (1)
Miscellaneous antibacterial drugs (1999) (1)
Medical emoticons (2005) (1)
When I use a word . . . . Medical magic (2022) (1)
Forgotten Primodos story and the roles of general practitioners (2020) (1)
A medical alphabet (2000) (1)
The British Journal of Clinical Pharmacology Editors’ Report for 2002 (2003) (1)
When I use a word . . . . The efficiency paradox (2021) (1)
Moving about. (2005) (1)
THE PHARMACOKINETICS OF INTRAVENOUS STABLE STRONTIUM IN HEALTHY-VOLUNTEERS (1989) (1)
Deaths from cardiovascular disease: A systematic analysis of coroners’ reports to prevent future deaths in England and Wales (2020) (1)
Adverse events in British hospitals. Retrospective case record analysis has been superseded. (2001) (1)
When I use a word . . . . Medical patronymics, metronymics, and papponymics (2022) (1)
The Disposition of Oral Rubidium Chloride in Essential Hypertension (1982) (1)
Treatment of yellow oleander poisoning with multiple dose activated charcoal: a randomized controlled trial (2003) (1)
Extending anticoagulation treatment for unprovoked venous thromboembolism (2019) (1)
When I use a word . . . . St Bartholomew—onomastics and reputation (2022) (1)
When I use a word . . . . Too much healthcare—incompetence and hierarchiology (2022) (1)
PerspectivesKilling smokingConrad Keating, Smoking Kills: The Revolutionary Life of Richard Doll, Signal Books (2010), Pp. 495 £17·99., ISBN: 9781904955634 (2011) (1)
Disco dancing (2002) (1)
Features of this month's Journal (2003) (1)
Patient centred verbs (2002) (1)
2894 – THE USE OF QUANTITATIVE COLOUR VISION TESTING IN DIAGNOSING DIGITALIS TOXICITY (1978) (1)
Editors' review of 2006 and the BJCP prize. (2007) (1)
Chapter 3 Respiratory system (2005) (1)
Fillers (1998) (1)
When I use a word: Medical emoticons (2005) (1)
Global, regional & national consumption of controlled opioids (2020) (1)
Routes of drug administration: 2. Sublingual and buccal (1991) (1)
805 – THE EFFECT OF DIGOXIN THERAPY ON RED BLOOD CELL FUNCTION AND ITS RELATIONSHIP TO THE THERAPEUTIC RESPONSE (1978) (1)
The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6 (2019) (1)
An Evaluation of the Evidence of an Association between Montelukast and Suicide: A Publicity Exacerbated Signal? (2012) (1)
When I use a word . . . . Too much healthcare—Monitoring (2022) (1)
When I use a word . . . . Too little healthcare—coroners’ concerns (2022) (1)
When I use a word . . . . Remembrance of things past (2022) (1)
The diagnosis of art: Rachmaninov's hand span. (2006) (1)
Signs of love, not a love potion (2003) (1)
Monitoring theophylline treatment: Authors' reply (1993) (1)
When I use a word . . . . Medical anniversaries in 2023: The Lancet (2023) (1)
The diagnosis of art: Achilles Emperaire and spondyloepiphyseal dysplasia congenita. (2007) (1)
When I use a word . . . . Defining with finesse (2023) (1)
Good prescribing: benefits, hazards, harms, and risks (2016) (1)
"Open-access" publishing: first the evidence--then the verdict. (2006) (1)
THE EFFECTS OF LITHIUM, ETHACRYNIC-ACID, AND LOW POTASSIUM ON SPECIFIC LYMPHOCYTIC [H-3] OUABAIN BINDING (1985) (1)
A licence to cure (2015) (1)
When I use a word . . . .Diagnosing definitions (2023) (1)
Reporting of medication adherence in randomized controlled trials of pharmacological interventions for SARS-CoV-2: a cross-sectional analysis (2022) (0)
Pharmacology of drugs used to treat heart failure (2005) (0)
Chapter 34 – Vitamins, Amino Acids and Drugs and Formulations Used in Nutrition (2014) (0)
Blood, Blood Products, and Anaemia: Iron salts: BNF 9.1.1 (2005) (0)
Evidence based transatlantic orthography (2020) (0)
Factors predisposing to digitalis toxicity (1984) (0)
Treatment of poisoning: An approach to the poisoned patient (2005) (0)
Low-dose adrenaline, promethazine and hydrocortisone, (alone and in combination) in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double blind, placebo-controlled trial (2011) (0)
HEPATIC insufficiency. (1955) (0)
Gastric acid suppression: Misoprostol: BNF 1.3.4 and 10.1.1 (2005) (0)
Rheumatoid arthritis (disease-modifying drugs): BNF 10.1 (2005) (0)
Analgesics: Paracetamol (acetaminophen): BNF 4.7.1 (2005) (0)
WHEN I USE A WORD (1996) (0)
When I use a word . . . . Medical hyacinths (2022) (0)
Calcium channel blockers: Calcium channel blockers (see also individual sections): BNF 2.6.2 (2005) (0)
The matter with “issue” (2006) (0)
Antiviral Drugs: Drugs used to treat human immunodeficiency virus (HIV) infection: BNF 5.3 (2005) (0)
Adrenoceptor agonists: Adrenoceptor agonists (sympathomimetics): BNF 2.7 (2005) (0)
John Coakley Lettsom and the introduction of digitalis into clinical practice at the end of the eighteenth century. (2002) (0)
Medical Classics: Phantastica (2007) (0)
Antiarrhythmic Drugs: Quinidine: BNF 2.3.2 (2005) (0)
Liver, biliary system, and lipids: Cholic acids: BNF 1.9.1 (2005) (0)
ALTEREDDISTRIBUTION OFDIGOXIN INRENALFAILURE-ACAUSEOFDIGOXINTOXICITY? (1976) (0)
MONITORINGDIGOXINTHERAPY: 111. HOW USEFULARETHENOMOGRAMS? (1978) (0)
Drugs used to treat cancer: Platinum compounds: BNF 8.1.5 (2005) (0)
Checklist for standardized reporting of drug–drug interaction management guidelines (2013) (0)
Ischaemic heart disease: Pharmacology of drugs used to treat myocardial infarction: BNF 2.10 (2005) (0)
GLAUCOMA: Acetylcholine receptor agonists: BNF 11.6, 12.3.5, and 7.4.1 (2005) (0)
74 Which medicines do we need? development of an outcomes-based approach to essential medicines lists (2018) (0)
Obstetrics: Prostaglandins: BNF 7.1.1, 7.4.5, and 11.6 (2005) (0)
Liver, biliary system, and lipids: Colestyramine and colestipol: BNF 2.12 and 1.9.2 (2005) (0)
Adverse drug reactions are true crime stories (2017) (0)
Thyroid disease: Thyroid hormones: BNF 6.2.1 (2005) (0)
System rather than target driven approach needed to discover beneficial drug effects (2012) (0)
Chapter 7 Kidneys and the urinary tract (2005) (0)
Drugs and the kidneys: Renal insufficiency: BNF 7.4.3 (2005) (0)
Chapter 29 – Antiviral drugs (2011) (0)
Book review (1995) (0)
Sex Steroids: Anti-androgens: BNF 8.3.4.2, 6.4.2. and 13.62 (2005) (0)
The hours that doctors work (1999) (0)
Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios (2003) (0)
Liver, biliary system, and lipids: HMG CoA reductase inhibitors ('statins'): BNF 2.12 (2005) (0)
Some Basic Concepts: Renal insufficiency (2005) (0)
Asthma and Copd: Cromones: BNF 3.3.1 and 1.5 and 11.4.2 (2005) (0)
Analysis NICE and new: appraising innovation (2010) (0)
Antiarrhythmic Drugs: Disopyramide: BNF 2.3.2 (2005) (0)
Antibacterial Drugs: Tetracyclines: BNF 5.1.3 and 13.6.2 (2005) (0)
Three questions for prescribers (2010) (0)
Interactions that matter: 10 Antiarrhythmic drugs (1987) (0)
Blood, Blood Products, and Anaemia: Deferoxamine (desferrioxamine): BNF 9.1.3 (2005) (0)
Musculoskeletal and joints (2011) (0)
When i use a word ... changing your practice. (2010) (0)
NICE and new : appraising innovation Innovation is essential in drug development but is not cheap (2010) (0)
Drugs used to treat cancer: Cyclophosphamide: BNF 8.1.1 (2005) (0)
ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 (2006) (0)
Chapter 27 - Antifungal drugs (2009) (0)
The Hitchhiker ’ s Guide to Clinical Pharmacology Pharmacodynamics : How Drugs Work (2016) (0)
METABOLISM OFAN ORAL TRYPTOPHANLOAD. I:EFFECTSOFDOSEAND PRETREATMENTWITHTRYPTOPHAN (1980) (0)
Protean elephants (1998) (0)
When I use a word . . . . Medical anniversaries in 2023: Théodore de Mayerne (2023) (0)
Some Basic Concepts: Drug interactions (2005) (0)
DEPRESSION: Venlafaxine: BNF 4.3.4 (2005) (0)
Anxiolytics and Hypnotics: Benzodiazepine-like hypnotics: BNF 4.1.1 (2005) (0)
The diagnosis of art: Dr Péan's operation (2008) (0)
David Grahame-Smith (2011) (0)
134 Compliance of randomized control trials investigating pharmacological interventions for SARS-CoV-2 with medication adherence reporting standards: a cross sectional analysis (2022) (0)
Immunoglobulins: BNF 14.5 and 14.2 (2005) (0)
Drugs and the Kidneys: Drugs used in the management of chronic renal insufficiency: BNF 7.4.3 (2005) (0)
Diagnostic agents: Not all listed in BNF (2005) (0)
Chapter 5 Infections (2005) (0)
ADDED VALUE IN DRUG-THERAPY - INTRODUCTION (1994) (0)
Live Long and Prosper: A Mass Strategy for Treating the Factors Associated with Ischaemic Heart Disease and Stroke (2004) (0)
Parkinson's Disease: Pharmacology of drugs used to treat Parkinson's Disease (2005) (0)
Depression: Tricyclic antidepressants: BNF 4.3.1,6.1.5,4.7.4.2,and 7.4.2 (2005) (0)
Evaluation of pharmacological evidence for forensic purposes. (2012) (0)
Retinoids: BNF 13.6.1, 8.1.5, 13.5.2, and 13.8.1 (2005) (0)
Reducing prescribing errors through medical education (2011) (0)
Asthma and Copd: Pharmacology of drugs used to treat asthma: BNF 3.1 (2005) (0)
CAUTIONARY AND ADVISORY LABELS (1976) (0)
Anticonvulsants: Sodium valproate: BNF 4.8.1 (2005) (0)
Rheumatoid arthritis: Gold salts: BNF 10.1.3 (2005) (0)
Antiplatelet Drugs: Dipyridamole: BNF 2.9 (2005) (0)
General anesthetics and therapeutic gases (1997) (0)
When I use a word . . . . Counterfactual medical history: the death of Charles II (2022) (0)
Up by dose (1997) (0)
The diagnosis of art: Lowry's Cripples (2007) (0)
When I use a word . . . . Elizabethan (2022) (0)
When I use a word: HARMful reactions (2004) (0)
2653 – MONITORING DIGOXIN THERAPY: COMPARISON BETWEEN TISSUE RESPONSE AND CLINICAL EFFECTS (1978) (0)
Preface to the Sixth Edition (2012) (0)
Gout: Colchicine: BNF 10.1.4 (2005) (0)
Stimulation of potassium ((86)rubidium) efflux from human platelets by external potassium and its inhibition by bumetanide: Evidence for Na/K/2Cl co-transport (1996) (0)
When I use a word . . . . The New Sydenham Society Lexicon (2023) (0)
MONITORING THEOPHYLLINE TREATMENT - REPLY (1993) (0)
Features of this month's Journal: Editor's View (2003) (0)
Chapter 1 Gastrointestinal system (2014) (0)
Antimalarial Drugs: Antimalarial drugs: BNF 5.4.1 (2005) (0)
Anxiolytics and Hypnotics: Clomethiazole (chlormethiazole): BNF 4.1.1 and 4.10 (2005) (0)
THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE (1982) (0)
Single or dual antiplatelet therapy after a transient ischaemic attack or minor ischaemic stroke? (2019) (0)
Anxiolytics and Hypnotics: Benzodiazepines: BNF 4.1.1, 4.1.2 and 4.8.2 (2005) (0)
Abnormal functions of pottasium channels in the platelets of patients with Alzheimer's disease (1998) (0)
and poor prescribing is continual (2017) (0)
Ischaemic Heart Disease: Nicorandil: BNF 2.6.3 (2005) (0)
Book review (2004) (0)
Ischaemic Heart Disease: Nitrate drugs: BNF 2.6.1 (2005) (0)
When I use a word . . . . Examining the efficiency paradox (2021) (0)
Urinary tract: Alpha-adrenoceptor antagonists (alpha-blockers): BNF 7.4.1 and 2.5.4 (2005) (0)
When I use a word . . . . More medical magic (2022) (0)
Antibacterial Drugs: Macrolide antibiotics: BNF 5.1.5 (2005) (0)
When I use a word: Nauseated/nauseous (2006) (0)
Consultation (1985) (0)
Calcium Channel Blockers: Benzthiazepines (diltiazem): BNF 2.6.2 and 2.3.2 (2005) (0)
Parkinson's Disease: Entacapone: BNF 4.9.1 (2005) (0)
Acknowledgement to Referees (2014) (0)
Exciting Times in the Accounts Department (1995) (0)
INVIVO EVIDENCE OF REDUCED CATION-TRANSPORT IN CHRONIC-RENAL-FAILURE (1983) (0)
Prescribing: 'Off-licence' drugs (2005) (0)
Drugs used to treat cancer: BNF 8.1 (2005) (0)
Book reviewNutritional Supplements in Sport, Exercise and Health: An A–Z Guide, Linda M. Castell, Samantha J. Stear, Louise M. Burke (Eds.), Routledge (2015), p. 426, £35.99. ISBN 978-1-138-77764-4 (2016) (0)
Somatostatin and analogues: BNF 8.3.4.3 (2005) (0)
The interpretation of bradycardia in digitalized patients (1981) (0)
Medicine and the media (1999) (0)
DIGOXINTHERAPY: TEXTBOOKS,THEORYAND PRACTICE (1976) (0)
Chapter 11 Eye (2005) (0)
Anticoagulants: Heparins(unfractionated and low molecular weight): BNF 2.8.1 (2005) (0)
Chapter 12 Skin (2005) (0)
Digitalis intoxication. (1983) (0)
Anticholinesterases: Acetylcholinesterase inhibitors: BNF 10.21,4.1.1,15.1.6,7.4.1, and 1.6.2 (2005) (0)
Killing smoking Conrad Keating Smoking Kills: The Revolu (2011) (0)
Drugs affecting muscle: Neuromuscular blocking drugs: BNF 15.1.5 (2005) (0)
Immunomodulation Treatment for Ulcerative Colitis (2020) (0)
Drugs affecting muscle:Botulinum toxin: BNF 4.9.3 (2005) (0)
Antifungal Drugs: Imidazole and triazole antifungal drugs: BNF 5.2, 7.2.2, 12.3.2, and 13.10.2 (2005) (0)
Essential reading matter (1999) (0)
When I use a word . . . . Medical aphorisms (2022) (0)
Blood, Blood Products, and Anaemia: Factor VIII and related products: BNF 9.1 (2005) (0)
Blood, blood products, and anaemia: Drugs and anaemia: BNF 9.1 (2005) (0)
Fin de siècle countdown (1999) (0)
When I use a word . . . . Medical trigger warnings (2022) (0)
Diabetes mellitus: Glucagon: BNF 6.1.4 (2005) (0)
Smoking Cessation: Amfebutamone (bupropion): BNF 4.10 (2005) (0)
The diagnosis of art: Achilles Emperaire and spondyloepiphyseal dysplasia congenita (2007) (0)
Drugs affecting gi motility: Loperamide (Immodium ®): BNF 1.4.2 (2005) (0)
Parkinson's Disease:Levodopa (L-dopa): BNF 4.9.1 (2005) (0)
The diagnosis of art: Valentin le désossé and Ehlers-Danlos syndrome (2007) (0)
ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 (2006) (0)
Ischaemic Heart Disease: Beta-adrenoceptor antagonists ('beta-blockers'): BNF 2.4, 2.5.5, 6.2.2, 4.7.4, 11.6 (2005) (0)
Antiarrhythmic Drugs: Procainamide: BNF 2.3.2 (2005) (0)
Geographic metals (2007) (0)
Problems with using mechanisms to solve the problem of extrapolation (2013) (0)
SODIUM EFFLUX AND ESSENTIAL HYPERTENSION (1982) (0)
eGFR in changing drug regimens (2007) (0)
Herxheimer, Andrew (1925–2016), physician and clinical pharmacologist (2020) (0)
Theeffect ofnifedipine onthedisposition ofstrontium gluconate used asakinetic marker forcalcium inhealthy volunteers (1991) (0)
Drugs that affect blood coagulation, fibrinolysis, and hemostasis (2010) (0)
Minerals: Potassium chloride: BNF 9.2 (2005) (0)
When I use a word…: Crosses and stars (1997) (0)
Antiarrhythmic Drugs: Cardiac glycosides (digitalis): BNF 2.1.1, 2.3.1, and 2.5.5 (2005) (0)
Abnormal potassium channels in Alzheimer's disease (1999) (0)
Medication and health in the workplace (2013) (0)
Chapter 4 Central nervous sytem (2005) (0)
Drugs for erectile dysfunction: Sildenafil (Viagra®): BNF 7.4.5 (2005) (0)
Antiemetics: Serotonin 5-HT3 receptor antagonists: BNF 4.6 (2005) (0)
When I use a word . . . . Preventing future deaths—problems and solutions (2022) (0)
Kidneys and the urinary tract (2011) (0)
Drugs and the Kidneys: Drugs and renal stones: BNF 7.4.3 (2005) (0)
Great American Novels (2014) (0)
HOW THE ACTIVITY AND NUMBERS OF SODIUM POTASSIUM PUMPS IN HUMAN LYMPHOCYTES ARE REGULATED (1994) (0)
Anticonvulsants: Lamotrigine: BNF 4.8.1 (2005) (0)
Minerals: Calcium salts: BNF 9.5.1.1 and 9.6.4 (2005) (0)
Analgesics: Capsaicin: BNF 10.3.2,4.7.3 and 6.1.5 (2005) (0)
Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (0)
Medication errors detected in non-traditional databases: types of errors in methotrexate dosing as listed in four different Danish registers (2015) (0)
WHEN I USE A WORD.. (1996) (0)
Twice blessed (2011) (0)
Serious interaction between digoxin and warfarin (multiple letters) (2002) (0)
Authors' response to Hasan (2011) (0)
Blood pressure meta-analysis highlights an implementation gap (2022) (0)
The diagnosis of art: Millais' Blind Girl (2008) (0)
The diagnosis of art: Ernst Ludwig Kirchner's ‘nervous breakdown’ (2010) (0)
Blood, Blood Products, and Anaemia: Folic acid and folinic acid: BNF 9.1.2 and 8.1 (2005) (0)
Calcium Channel Blockers: Phenylalkylamines (verapamil): BNF 2.6.2 and 2.3.2 (2005) (0)
Diuretics: Spironolactone: BNF 2.2.3, 2.2.4 and 2.5.5 (2005) (0)
When I use a word . . . . Unnecessary, hateful, sickening words (2022) (0)
RCTs (Randomized Controlled Trial, Druin Burch, 'Martindale') (2008) (0)
Sometimes, never (2006) (0)
When I use a word . . . . Bioscience journals—an open and shut case? (2022) (0)
When I use a word: Incestuous sheets (2005) (0)
Ischaemic Heart Disease: Angiotensin receptor antagonists/blockers (ARBs): BNF 2.5.5.2 (2005) (0)
Antibacterial Drugs: Glycopeptide antibiotics: BNF 5.1.7 (2005) (0)
THE EFFECTS OF LITHIUM ON NA/K PUMP NUMBERS AND ACTIVITY IN HUMAN ISOLATED LYMPHOCYTES INVITRO (1989) (0)
Drugs used to treat cancer: Adverse effects of cytotoxic chemotherapy: BNF 8.1 (2005) (0)
Antibacterial Drugs: Aminoglycoside antibiotics: BNF 5.1.4 (2005) (0)
Corticosteroids: BNF 6.3 (2005) (0)
Prescribing: Writing a prescription (2005) (0)
Changing the doses of drugs (2005) (0)
MONITORING TREATMENT WITH AMINOGLYCOSIDE ANTIBIOTICS - REPLY (1993) (0)
Book Review (2005) (0)
Analgesics: Codeine phosphate and dihydrocodeine: BNF 4.7.1 and 4.7.2, 1.4.2 and 3.9.1 (2005) (0)
EVIDENCE FOR INCREASED INVIVO NA+/H+ ANTIPORTER ACTIVITY IN SKELETAL-MUSCLE OF SPONTANEOUSLY HYPERTENSIVE RATS (1990) (0)
Anticonvulsants: Carbamazepine: BNF 4.8.1,4.7.3,6.5.2 and 6.1.5 (2005) (0)
Analgesics: Palliative care: BNF: Prescribing in palliative care (2005) (0)
Elsevier's Dictionary of Abbreviations, Acronyms, Synonyms and Symbols Used in Medicine, 2nd enlarged edition (2005) (0)
Homogenous/homogeneous (1999) (0)
The Doctor in Literature: Satisfaction or Resentment? (2006) (0)
Aronson, Jeffrey: transcript of an audio interview (25-Apr-2016) (2016) (0)
Analgesics: Opiates and non-opiate narcotic analgesics: BNF 4.7.2 and 15.1.4.3 (2005) (0)
ROUTES OF DRUG ADMINISTRATION : 7. SUBCUTANEOUS ADMINISTRATION (1998) (0)
Antiplatelet Drugs: Acetylsalicylic acid (aspirin): BNF 2.9 and 4.7.1 (2005) (0)
BALANCED PRESCRIBING AND THE INFORMATION THAT WE NEED TO ACHIEVE IT (2009) (0)
Diuretics: Loop diuretics: BNF 2.2.2 and 2.2.4 (2005) (0)
Allergy and immunity (1999) (0)
A tribute to Graham Dukes (2000) (0)
Lost in Translation: A Multilingual Survey of Interlinguistic Variations in Terms Used in Pharmacovigilance (2022) (0)
WHEN I USE A WORD (1996) (0)
A systematic review: adverse events in patients taking macrolides (2019) (0)
Obesity: Sibutramine: BNF 4.5.2 (2005) (0)
Antiviral Drugs: Antiviral guanine derivatives: BNF 5.3, 11.3.3, and 13.10.3 (2005) (0)
When I use a word . . . Medical definitions: Pharmacovigilance signals (2023) (0)
Lack of follow-up negates value of case reports (2017) (0)
When I use a word . . . . Counterfactual medical history: Milton’s poetry (2022) (0)
Immunosuppression: Azathioprine and mercaptopurine: BNF 8.2, 8.1.3, 1.5, 10.1.3 and 10.2.1 (2005) (0)
Metal Ions in Neurology and Psychiatry Edited by S. Gabay, J. Harris and B. T. Ho. Neurology and Neurobiology. Vol. 15. 409 pp. ISBN 0-8451-2717-9. Price: $94. Alan R. Liss, Inc., 1985 (1986) (0)
Classifying adverse drug reactions in the 21 st century (2006) (0)
Why patients and healthcare professionals do or do not report suspected adverse drug reactions: A systematic review of the theoretical literature (2019) (0)
Prolonged half-life ofverapamil ina caseofoverdose: implications fortherapy (1995) (0)
Inhibition ofbinding ofinterferon-y toits receptor by salicylates usedininflammatory bowel disease (2011) (0)
Antiarrhythmic Drugs: Flecainide: BNF 2.3.2 (2005) (0)
UP-REGULATION OF NA/K PUMPS BY LOOP DIURETICS - NONINVOLVEMENT OF NA/K/2CL COTRANSPORT (1995) (0)
Endocrine system; obstetrics and gynaecology (2011) (0)
Medical Devices: Classification and Analysis of Faults Leading to Harms (2019) (0)
Sex Steroids: Oral contraceptives: BNF 7.3 (2005) (0)
Disco dancing - Invited comment (2002) (0)
When I use a word . . . . Lexicographical anniversaries (2022) (0)
Sex steroids: Oestrogens and hormone replacement therapy (HRT): BNF 6.4.1, 7.2.1, and 8.3.1 (2005) (0)
Rheumatoid arthritis: Leflunomide: BNF 10.1.3 (2005) (0)
Remembering Eric Korn (2015) (0)
Treatment of Pulmonary Oedema (1956) (0)
Antedating examples of “chickenpox” (2022) (0)
Appendix 1: Web Sites Relevant to Pharmacovigilance—An Analysis of Contents (2012) (0)
Drugs and the Kidneys: Drugs and renal replacement therapy (dialysis or filtration): BNF 7.4.3 (2005) (0)
The effects of different statins on serum LDL cholesterol concentrations: A systematic review and meta-analysis of in vivo dose-response curves (2020) (0)
Drugs affecting muscle: Dantrolene: BNF 15.1.8 and 10.2.2 (2005) (0)
Relief of pain and anaesthetic drugs (2011) (0)
Benjamin Brodie's infamous case of Isambard Kingdom Brunel and an inhaled gold coin (2011) (0)
Antimuscarinic drugs: Muscarinic acetylcholine receptor antagonists (atropine and related compounds): BNF 15.1.3,4.6,4.9.2,7.4.2 and 11.5 (2005) (0)
Chapter 14 Immunological products and vaccines (2005) (0)
Digoxin revisited. (1998) (0)
Gout: Allopurinol: BNF 10.1.4, and 8.1 (2005) (0)
Data for: Are poor-quality guidelines associated with greater non-adherence? A meta-epidemiological study (2018) (0)
Antibacterial Drugs: Cephalosporins and cephamycins: BNF 5.1.2 (2005) (0)
WHEN I USE A WORD (1996) (0)
Anecdotage (2003) (0)
Parkinson's Disease: Dopamine receptor agonists: BNF 4.9.1 and 6.7.1 (2005) (0)
Chapter 6 - Antipsychotic drugs (2014) (0)
Protocol: A systematic review and network meta-analysis of the effects of different doses of licensed statins on LDL cholesterol in humans in order to generate dose-response curves (2020) (0)
Nauseated/nauseous (2006) (0)
Liver, biliary system, and lipids: Fibrates: BNF 2.12 (2005) (0)
Diuretics: Potassium-sparing diuretics (amiloride and triamterene): BNF 2.3.2 and 2.2.4 (2005) (0)
Osteoporosis: Bisphosphonates: BNF 6.6.2 and 9.5.1.2 (2005) (0)
Medication Errors: Relevance to Pharmacovigilance (2016) (0)
Analgesics: Gabapentin: BNF 4.7.3 and 4.8.1 (2005) (0)
When I use a word...: Fillers (1998) (0)
When I use a word …: Fortysomething (1997) (0)
DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE (1983) (0)
Fibrinolytic drugs: BNF 2.10.2 and 13.11.7 (2005) (0)
Antibacterial Drugs: Carbapenems: BNF 5.1.2 (2005) (0)
Blood, Blood Products, and Anaemia: Colony stimulating factors: BNF 9.1.3 (2005) (0)
When I use a word . . . . Vaccination—rights and duties (2022) (0)
Fluorometric Assay of Digoxin (1977) (0)
Interferons: Interferons: BNF 8.2.4, 5.3, and 14.5 (2005) (0)
Antibacterial Drugs: Metronidazole and tinidazole: BNF 5.1.11 (2005) (0)
' s report Title : Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge : A Cluster Randomized Trial Version : 3 Date : 18 March 2012 (0)
Rheumatoid arthritis: Chloroquine and hydroxychloroquine: BNF 5.4.1 and 10.1.3 (2005) (0)
Migraine: Serotonin 5-HT1 receptor agonists ('triptans'): BNF 4.7.4 (2005) (0)
Blood, Blood Products, and Anaemia: Blood transfusion: BNF 9.1 (2005) (0)
Asthma and Copd: Short-acting β2 Long-acting β2 adrenoceptor agonists: BNF 3.1.1.1 (2005) (0)
Editors' Report for 2006 (2007) (0)
Calcium Channel Blockers: Dihydropyridines (nifedipine-like): BNF 2.6.2 (2005) (0)
Sex Steroids: Androgens and anabolic steroids: BNF 6.4.2 and 6.4.3 (2005) (0)
When I use a word . . . . The Lelamour Herbal (2023) (0)
Disseminated Acanthamoebiasis: Abstracts (2008) (0)
Chapter 8 Malignant disease and immunosuppression (2005) (0)
Chapter 10 Musculoskeletal and joints (2005) (0)
Lickerish liquorice (2012) (0)
Diuretics: Thiazide and thiazide-like diuretics: BNF 2.2.1,2.5.5, and 6.5.2 (2005) (0)
Rheumatoid arthritis: Tumour necrosis factor (TNF) blocking drugs: BNF 10.1.3 and 1.5 (2005) (0)
Antibacterial Drugs: Penicillins: BNF 5.1.1 (2005) (0)
Some Basic Concepts: Placebos (2005) (0)
When I use a word . . . . Some words about the climate (2022) (0)
Drugs used to treat cancer: Antimetabolite drugs: BNF 8.1.3, 10.1.3, and 13.5.2 (2005) (0)
Some Basic Concepts: Adverse drug reactions (2005) (0)
Hypertension: An approach to the treatment of hypertension: BNF 2.5 (2005) (0)
Sex Steroids: Progestogens: BNF 6.4.1.2, 8.3.2, and 7.3 (2005) (0)
Sex Steroids: Gonadorelin analogues: BNF 6.7.2 and 8.3.4.1 & 2 (2005) (0)
Antiplatelet Drugs: Clopidogrel: BNF 2.9 (2005) (0)
Drugs used to treat cancer: Chlorambucil: BNF 8.1.1 (2005) (0)
David Grahame Grahame-Smith: clinical pharmacologist. 1933-2011. (2012) (0)
Drugs used to treat cancer: Taxanes: BNF 8.1.5 (2005) (0)
Drugs affecting gi motility: Co-phenotrope (Lomotil®): BNF 1.4.2 (2005) (0)
Some Basic Concepts: Efficacy of drugs (2005) (0)
Asthma and Copd: Short-acting β2 adrenoceptor agonists: BNF 3.1.1.1 and 7.1.3 (2005) (0)
Antidotes: Acetylcysteine (Parvolex®): BNF Emergency treatment of poisoning (2005) (0)
Today's Treatment (1981) (0)
Write on. (2005) (0)
Increased Na+ ???H+ antiport activity in vivo in skeletal muscle of spontaneously hypertensive rats can be reversed by nifedipine (1990) (0)
The diagnosis of art: Lowry’s cripples. (2007) (0)
Photosensitivity reactions and skin tumours associated with voriconazole (2015) (0)
Chapter 21 – Diuretics (2009) (0)
When I use a word …: A time to be born … (1997) (0)
Chapter 9 Nutrition and blood (2005) (0)
Towards a single VOICE for European clinical pharmacology: proposals for future developments (2013) (0)
Antibacterial Drugs: Quinolone antibiotics: BNF 5.1.12 (2005) (0)
Proceedings: Cellular biochemical pharmacology in monitoring drug therapy. (1976) (0)
Was William Harvey’s commitment to experimentation reflected in his clinical practice? (2021) (0)
When I use a word . . .: Re: re- (2001) (0)
Monthly injections (2000) (0)
Antibacterial Drugs: Sulfonamides and trimethoprim: BNF 5.1.8 and 13.10.1.1 (2005) (0)
Gastric acid suppression: Histamine H2 receptor antagonists: BNF 1.3.1 (2005) (0)
Drugs used to treat cancer: Vinca alkaloids: BNF 8.1.4 (2005) (0)
Antifungal Drugs: Polyene antifungal drugs: BNF 5.2, 7.2.2, 12.3.2, and 13.10.2 (2005) (0)
Psychoses and Bipolar Disorder: Antipsychotic/neuroleptic drugs: BNF 4.2 (2005) (0)
Drugs used to treat cancer: Methotrexate: BNF 8.1.3, 10.1.3, and 13.5.2 (2005) (0)
When I use a word . . . . Values (2022) (0)
Introducing the BMJ EBM series: Coroners’ Concerns to Prevent Harms - A series of coroners’ case reports to serve patient safety and educate the public, clinicians, and policymakers (2020) (0)
CHANGESINCARDIAC GLYCOSIDERECEPTORSITES, 86RUBIDIUM UPTAKEAND INTRACELLULAR SODIUMCONCENTRATIONS INTHE ERYTHROCYTES OFPATIENTS RECEIVING DIGOXINDURINGTHEEARLYPHASES OFTREATMENTOFCARDIACFAILUREIN REGULARRHYTHMAND OFATRIALFIBRILLATION (1979) (0)
Effects of homocysteine on potassium channels in human platelets (1999) (0)
Interaction between the Na+/K+/2Cl(-) and K+/Cl- co-transporters in human platelets (1997) (0)
Vitamins: Vitamin D analogues: BNF 9.6.4 and 13.5.2 (2005) (0)
Drugs and the Kidneys: Drug-induced renal damage: BNF 7.4.3 (2005) (0)
Asthma and Copd: Bronchodilatory muscarinic receptor antagonists: BNF 3.1.2 (2005) (0)
HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias. (1990) (0)
Treatment Of Poisoning: Activated charcoal: BNF Emergency treatment of poisoning (2005) (0)
HARMful reactions (2004) (0)
Asthma and Copd: Xanthine derivatives: BNF 3.1.3 (2005) (0)
The first description of hayfever? Response (2011) (0)
The clinical, haemodynamic, and pharmacological consequences of withdrawal of digoxin after long-term treatment in patients with heart failure in sinus rhythm (1986) (0)
27 - Antifungal drugs (2012) (0)
Post-Marketing Withdrawal Of Medicines Because of Adverse Drug Reactions: An Analysis of Anti-Obesity Medications (2015) (0)
Antiplatelet Drugs: Glycoprotein IIb/IIIa antagonists: BNF 2.9 (2005) (0)
When I use a word: Faux amis (2005) (0)
The British Journal of Clinical Pharmacology Editors’ Report for 2003. (2004) (0)
‘Open-Access’ Publishing: First the Evidence—then the Verdict (2006) (0)
The In VIVO Disposition of Lithium in Patients with Untreated Essential Hypertension (1988) (0)
Aronson, Jeffrey: transcript of a video interview (25-Apr-2016) (2016) (0)
Antituberculosis Drugs: Antituberculosis drugs: BNF 5.1.9 (2005) (0)
Was this Thomas Willis's greatest clinical success? (2021) (0)
Medicine in Staffordshire. (1977) (0)
Drugs affecting muscle: Baclofen: BNF 10.2.2 (2005) (0)
When I use a word . . . . Coronership—a lexicographic puzzle (2022) (0)
LONG-TERM EFFECTS OF GROWTH IN LOW K-MEDIUM ON SODIUM-PUMP ACTIVITY IN HUMAN CULTURED-CELLS (1993) (0)
Drugs that affect autonomic functions or the extrapyramidal system (2009) (0)
Inflammatory bowel disease: Sulfasalazine: BNF 1.5 and 10.1.3 (2005) (0)
A silver anniversary and a tribute to our contributors (2002) (0)
Smoking cessation: Nicotine: BNF 4.10 (2005) (0)
Diabetes mellitus: Thiazolidinediones ('glitazones'): BNF 6.1.2.3 (2005) (0)
The diagnosis of art: Alice, the Duchess, Sir John Tenniel, foxgloves, and roses (2007) (0)
The Diagnosis of Art: Rachmaninov's Hand Span (2006) (0)
Depression: Monoamine oxidase inhibitors (MAOIs): BNF 4.3.2 and 4.9.1 (2005) (0)
Monitoring lithium treatment: Authors' reply (1993) (0)
Clinical, haemodynamic, andpharmacological effects ofwithdrawal andreintroduction ofdigoxin in patients withheart failure insinus rhythmafter long termtreatment (1989) (0)
Medical Devices: Definition, Classifications, and Nomenclatures (2018) (0)
When I use a word ... Innovations--'The Births of Time'. (2012) (0)
WHEN I USE A WORD .. (1996) (0)
When I use a word . . . . Medical counterfactuals (2022) (0)
Minerals: Magnesium sulfate: BNF 9.5.1.3 (2005) (0)
Drugs used to treat cancer: Cytotoxic antibiotics: BNF 8.1.2 (2005) (0)
Radiological contrast agents (2010) (0)
Spitting images: our medical philologist, Jeff Aronson, comments (2010) (0)
Blood, Blood Products, and Anaemia: Vitamin B12: BNF 9.1.2,8.1 (2005) (0)
Central nervous system (2011) (0)
The Oxford Catalogue of Opioids (2019) (0)
Drugs used to treat cancer: Cytotoxic monoclonal antibodies: BNF 8.1.5 (2005) (0)
When I use a word …: Spurious words (1998) (0)
Some Basic Concepts: Drug therapy and breastfeeding (2005) (0)
Homocysteine inhibition of system y(+)L in human platelets: implications for atherosclerosis in uraemia (2000) (0)
Christmas 2009: Years Like This Patent medicines and secret remedies (2009) (0)
Inflammatory bowel disease: Mesalazine and related compounds (aminosalicylates): BNF 1.5 (2005) (0)
Immunosuppression: Ciclosporin, tacrolimus, and sirolimus: BNF 8.2.2 and 13.5.3 (2005) (0)
Antiarrhythmic Drugs: Amiodarone: BNF 2.3.2 and 2.7.3 (2005) (0)
Analgesics: Lidocaine (lignocaine): BNF 2.3.2 and 15.2 (2005) (0)
Incestuous sheets (2005) (0)
Chapter 13 Poisoning (2005) (0)
Antidotes: Penicillamine: BNF 9.8.1, 10.1.3, and Emergency treatment of poisoning (2005) (0)
When I use a word . . . .Devising bioscience definitions (2023) (0)
Analgesics: Non-steroidal anti-inflammatory drugs (NSAIDs): BNF 10.1.1 and 15.1.4.2 (2005) (0)
The importance of using placebo controls in nonpharmacological randomised trials (2022) (0)
When I use a mocking bird (2002) (0)
Glaucoma: Carbonic anhydrase inhibitors: BNF 11.6, 4.8 and 2.2.7 (2005) (0)
Book Review Pharmacotherapy: A pathophysiologic approach Edited by Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, and L. Michael Posey. 2440 pp., illustrated. Stamford, Conn., Appleton & Lange, 1999. $150. 0-8385-7691-5 (2000) (0)
Thyroid Disease: Carbimazole: BNF 6.2.2 (2005) (0)
Drugs affecting gi motility: Constipation: BNF 1.6 (2005) (0)
Tom Swifties (2008) (0)
Ischaemic Heart Disease: Angiotensin converting enzyme inhibitors (ACE inhibitors): BNF 2.5.5.1 (2005) (0)
DEPRESSION: Selective serotonin reuptake inhibitors (SSRIs): BNF 4.3.3 (2005) (0)
When I use a word . . . . Data—usage and ownership (2023) (0)
When I use a word . . . . Nasty medical eponyms (2021) (0)
THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART (1982) (0)
David E Allen and Gabrielle Hatfield, Medicinal plants in folk tradition: an ethnobotany of Britain and Ireland , Portland, OR, and Cambridge, Timber Press, 2004, pp. 431, illus., £22.50 (hardback 0-88192-638-8). (2005) (0)
Vaccines: UK immunization schedule: BNF 14.1 (2005) (0)
When I use a word . . . . Medical words newly logged in the OED in December 2021 (2022) (0)
Comprar Meyler's Side Effects Of Endocrine And Metabolic Drugs | J. Aronson | 9780444532718 | Academic Press (2009) (0)
Chapter 15 The treatment of pain (2005) (0)
Psychoses and Bipolar Disorder: Lithium: BNF 4.2.3 (2005) (0)
UP-REGULATION OF SODIUM-POTASSIUM PUMPS BY THE LOOP DIURETIC ETHACRYNIC-ACID - POSSIBLE ROLE OF PHOSPHOINOSITIDE TURNOVER (1995) (0)
An approach to rational prescribing (2005) (0)
Asthma and Copd: Leukotriene receptor antagonists: BNF 3.3.2 (2005) (0)
University of Effects of antihypertensives, lipid-modifying drugs, glycaemic control drugs and sodium bicarbonate on the progression of stages 3 and 4 chronic kidney disease in adults (2019) (0)
Reducing the frequency of medication errors (2010) (0)
Gastric acid suppression: Proton pump inhibitors (PPIs): BNF 1.3.5 (2005) (0)
Classifying paradoxical adverse drug reactions (2017) (0)
Blood, Blood Products, and Anaemia: Erythropoietin (epoetin) and analogues: BNF 9.1.3 (2005) (0)
186 Compliance of randomized control trials investigating pharmacological interventions for SARS-CoV-2 with medication adherence reporting standards: a cross sectional analysis (2022) (0)
When I use a word . . . . Medical words of 1952—a jubilee celebration (2022) (0)
Antidotes: Naloxone: BNF Emergency treatment of poisoning and 15.1.7 (2005) (0)
PHARMACOKINETIC INVESTIGATIONOFTHE INTERACTION OFAZAPROPAZONE WITH PHENYTOIN (1983) (0)
When I use a word . . . Medical definitions: adverse events, effects, and reactions (2023) (0)
Antiarrhythmic Drugs: Adenosine: BNF 2.3.2 (2005) (0)
Monitoring treatment with aminoglycoside antibiotics: Authors' reply (1993) (0)
SIALADENITIS DUE TO IODINATED CONTRAST MEDIA ('IODIDE MUMPS') - EVIDENCE FOR TWO SEPARATE MECHANISMS (2011) (0)
The Words of Medicine: Sources, Meanings, and Delights (2001) (0)
Urinary Tract: Antidiuretic hormone (ADH, vasopressin) and analogues: BNF 7.4.1 and 7.4.2 (2005) (0)
133 Impact of novel social media interventions to correct the reporting of evidence (IN MICE): an interrupted time series study (2022) (0)
Corticosteroids: Glucocorticoids: BNF 6.3 (2005) (0)
When I use a word . . . . Medical wordbooks (2023) (0)
174 Impact of novel social media interventions to correct the reporting of evidence (IN MICE): an interrupted time series study (2022) (0)
When I use a word: Terrorist (2002) (0)
Drug–drug interactions (2018) (0)
HbA(1c) before and after starting treatment with metformin in a large diabetes type 2 cohort (2012) (0)
Diuretics: Sites of action of diuretics: BNF 2.2 (2005) (0)
When i use a word …: Sloe gin (1997) (0)
[H-3]-LABELED OUABAIN BINDING AND RB-86 UPTAKE IN POLYMORPHONUCLEAR AND MONONUCLEAR LEUKOCYTES (1983) (0)
Long-term monitoring in primary care for chronic kidney disease and chronic heart failure: a multi-method research programme (2021) (0)
Multidose activated charcoal for yellow oleander poisoning (2003) (0)
Effect of salt reduction on palatability of bread: a double-blind, randomized, crossover study (2018) (0)
Comprar Macromolecules: 4 Volume Set | Paul P. Glasziou | 9783527311712 | Wiley (2009) (0)
Monitoring cholesterol-modifying interventions: from principles to practice (2008) (0)
Preventable deaths involving opioids in England and Wales, 2013-2022: a systematic case series of coroners reports (2022) (0)
Diabetes mellitus: Meglitinides: BNF 6.1.2.3 (2005) (0)

This paper list is powered by the following services:

Other Resources About Jeffrey Aronson

What Schools Are Affiliated With Jeffrey Aronson?

Jeffrey Aronson is affiliated with the following schools:

Jeffrey Aronson's Academic­Influence.com Rankings